This invention relates to novel compounds of the Formulae I or II and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof which are useful for the therapeutic treatment of diseases associated with the modulation or inhibition of 11 β-HSD l in mammals.Formula (I).
这项发明涉及到式I或II的新化合物及其药用盐,以及与之相关的药物组合物,用于治疗与哺乳动物中11β-H
SD l的调节或抑制相关的疾病。Formula (I)。